Published in Cardiovasc Intervent Radiol on October 17, 2012
Endovascular intervention for peripheral artery disease. Circ Res (2015) 0.96
Role of the latest endovascular technology in the treatment of intermittent claudication. Ther Clin Risk Manag (2014) 0.75
Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment. Ont Health Technol Assess Ser (2015) 0.75
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet (2005) 7.25
Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med (2006) 6.51
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. Value Health (2007) 3.93
Medical treatment of peripheral arterial disease. JAMA (2006) 2.76
Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv (2011) 2.57
Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv (2010) 2.52
Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther (2012) 1.95
Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes (2010) 1.39
Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation (2007) 1.37
Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther (2009) 1.20
Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther (2011) 1.19
Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial. Health Technol Assess (2010) 1.08
Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther (2005) 1.06
Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. J Vasc Surg (2011) 1.03
Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology (2008) 0.88
Cost per day of patency: understanding the impact of patency and reintervention in a sustainable model of healthcare. J Vasc Surg (2008) 0.85
Management of peripheral arterial disease. Am Fam Physician (2004) 0.82
Are drug-eluting stents the future of SFA treatment? J Cardiovasc Surg (Torino) (2010) 0.81
Role of total endoluminal superficial femoral artery bypass. J Cardiovasc Surg (Torino) (2011) 0.81
Peripheral arterial disease in women: the effect of gender on diagnosis and treatment. Tex Heart Inst J (2011) 0.79
The potential role of DES in peripheral in-stent restenosis. J Cardiovasc Surg (Torino) (2010) 0.77
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol (2008) 4.12
European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens (2014) 2.28
Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res (2013) 2.05
Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant (2002) 2.01
A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low- to moderate-risk patients. J Vasc Surg (2011) 1.90
Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension (2010) 1.47
Combined retrograde stent-graft placement and surgical repair for a Stanford type A aortic dissection. J Endovasc Ther (2010) 1.38
Potential exposure to hepatitis C virus through accidental blood contact in interventional radiology. J Vasc Interv Radiol (2003) 1.29
Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther (2007) 1.18
Small bowel pseudomelanosis and oral iron therapy. Dig Endosc (2009) 1.18
Urgent capsule endoscopy is useful in severe obscure-overt gastrointestinal bleeding. Dig Endosc (2009) 1.18
Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2005) 1.15
Big data meets the electronic medical record: a commentary on "identifying patients at increased risk for unplanned readmission". Med Care (2013) 1.12
The significance of endoleaks in thoracic endovascular aneurysm repair. Ann Vasc Surg (2010) 1.10
Spontaneous renal artery dissection: long-term outcomes after endovascular stent placement. J Vasc Interv Radiol (2009) 1.05
Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Mod Pathol (2008) 1.05
Double-balloon enteroscopy and small bowel tumors: a South-European single-center experience. Dig Dis Sci (2008) 1.03
Simulation devices in interventional radiology: caveat emptor. Cardiovasc Intervent Radiol (2006) 1.02
Effect of portal hypertension in the small bowel: an endoscopic approach. Dig Dis Sci (2007) 1.00
Radial nerve compression by a large cephalic vein aneurysm: case report. J Vasc Surg (2003) 1.00
The effect of metoclopramide in capsule enteroscopy. Dig Dis Sci (2009) 0.93
Virtual chromoendoscopy can be a useful software tool in capsule endoscopy. Rev Esp Enferm Dig (2012) 0.93
Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies. Transpl Int (2003) 0.92
First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension. EuroIntervention (2012) 0.91
Diagnosis and surgical treatment of a Takayasu disease on an abdominal aortic dissection. Ann Vasc Surg (2011) 0.90
Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2009) 0.90
Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients. J Am Coll Cardiol (2012) 0.88
Successful retrieval of 29 ALN inferior vena cava filters at a mean of 25.6 months after placement. J Vasc Interv Radiol (2012) 0.88
Embolization of the internal iliac artery: cost-effectiveness of two different techniques. Cardiovasc Intervent Radiol (2008) 0.87
Expert consensus: Renal denervation for the treatment of hypertension. Diagn Interv Imaging (2012) 0.86
Compliance of abdominal aortic aneurysms: evaluation of tissue Doppler imaging. Ultrasound Med Biol (2004) 0.86
Arterial percutaneous angioplasty in upper limbs with vascular access devices for haemodialysis. Nephrol Dial Transplant (2002) 0.86
Hyperresponders vs. nonresponder patients after renal denervation: do they differ? J Hypertens (2014) 0.84
Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity. FEBS J (2013) 0.83
Cost-effectiveness of a fourth-generation combination immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen for the detection of HIV infections in the United States. HIV Clin Trials (2012) 0.83
Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Blood Press (2015) 0.82
Expert consensus: renal denervation for the treatment of arterial hypertension. Arch Cardiovasc Dis (2012) 0.82
Renal artery stenosis following renal denervation: a matter of concern. J Hypertens (2014) 0.81
Ruptured popliteal artery pseudoaneurysm complicating a femoral osteochondroma in a young patient. J Vasc Surg (2011) 0.81
Simulation devices in interventional radiology: validation pending. J Vasc Interv Radiol (2006) 0.81
Endoluminal gingival fibroblast transfer reduces the size of rabbit carotid aneurisms via elastin repair. Arterioscler Thromb Vasc Biol (2012) 0.80
Small-bowel capsule endoscopy in patients with suspected Crohn's disease-diagnostic value and complications. Diagn Ther Endosc (2010) 0.80
Implant degradation and poor healing after endovascular repair of abdominal aortic aneurysms: an analysis of explanted stent-grafts. J Endovasc Ther (2006) 0.79
Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria. Wien Klin Wochenschr (2014) 0.79
Spontaneous soft-tissue hemorrhage in anticoagulated patients: safety and efficacy of embolization. AJR Am J Roentgenol (2015) 0.79
SIR/RSNA/CIRSE Joint Medical Simulation Task Force strategic plan: executive summary. Cardiovasc Intervent Radiol (2007) 0.78
Complications of the access during aortic valve implantation through transfemoral access. Ann Vasc Surg (2011) 0.78
Microvascular plug: a new embolic material for hepatic arterial skeletonization. Cardiovasc Intervent Radiol (2014) 0.78
Predicting hospital readmission: different approaches raise new questions about old issues. Med Care (2013) 0.78
Management of painful pelvic bone metastasis of renal cell carcinoma using embolization, radio-frequency ablation, and cementoplasty: a prospective evaluation of efficacy and safety. Cardiovasc Intervent Radiol (2013) 0.78
Diffusion-weighted imaging for evaluation of uterine arterial embolization of fibroids. Magn Reson Med (2013) 0.78
Eligibility for renal denervation: anatomical classification and results in essential resistant hypertension. Cardiovasc Intervent Radiol (2014) 0.78
Clinical management of renal artery fibromuscular dysplasia: temporal trends and outcomes. J Hypertens (2014) 0.78
Compressive hematoma due to pseudoaneurysm of the right hepatic artery: a rare cause of obstructive jaundice after single-port cholecystectomy. Surg Laparosc Endosc Percutan Tech (2015) 0.77
Percutaneous manual aspiration embolectomy of renal vein thrombosis due to acute pyelonephritis. Cardiovasc Intervent Radiol (2007) 0.77
Compliance of abdominal aortic aneurysms evaluated by tissue Doppler imaging: correlation with aneurysm size. J Vasc Surg (2005) 0.77
[A thousand total colonoscopies: what is the relationship between distal and proximal findings?]. Acta Med Port (2009) 0.76
drug-eluting nitinol stent treatment of the superficial femoral artery and above-the-knee popliteal artery (the Zilver PTX single-arm clinical study): a comparison between diabetic and nondiabetic patients. Cardiovasc Intervent Radiol (2013) 0.76
[Renal-nerve ablation in patients with resistant hypertension: caution is still needed]. Presse Med (2011) 0.76
Solution and biological behaviour of enrofloxacin metalloantibiotics: a route to counteract bacterial resistance? J Inorg Biochem (2010) 0.76
Aortic compliance in healthy subjects: evaluation of tissue Doppler imaging. Ultrasound Med Biol (2004) 0.75
Spontaneous dissection of the renal arteries: a misdiagnosed but not infrequent disease! Cardiovasc Intervent Radiol (2009) 0.75
SIR/RSNA/CIRSE joint medical simulation task force strategic plan executive summary. J Vasc Interv Radiol (2009) 0.75
Embolization of life-threatening arterial rupture in patients with vascular Ehlers-Danlos syndrome. Cardiovasc Intervent Radiol (2013) 0.75
Applicability and mid-term results of endovascular treatment for descending thoracic acute aortic syndromes. Ann Vasc Surg (2013) 0.75
Postpartum hemorrhage treated with gelfoam slurry embolization using the superselective technique: immediate results and 1-month MRI follow-up. Cardiovasc Intervent Radiol (2012) 0.75
Simulation devices in interventional radiology: validation pending. J Vasc Interv Radiol (2009) 0.75
SIR/RSNA/CIRSE Joint Medical Simulation Task Force strategic plan executive summary. J Vasc Interv Radiol (2007) 0.75
Retrospective study of rapid-exchange monorail versus over-the-wire technique for femoropopliteal angioplasty. Cardiovasc Intervent Radiol (2007) 0.75
Transfemoral aortic valve implantation in a patient presenting with critical aortic stenosis and previously treated by endovascular aortic aneurysm repair. Heart (2012) 0.75
Round table discussion: potency--appropriate assays, hypoallergenic products. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess (2009) 0.75
Renal denervation and treatment-resistant hypertension: a matter of importance for interventional radiology. Diagn Interv Imaging (2012) 0.75
[Vascular Ehlers-Danlos syndrome]. Presse Med (2006) 0.75
[Management of a patient with critical limb ischemia]. Rev Prat (2005) 0.75
Spontaneous fungal peritonitis: a rare but severe complication of liver cirrhosis. Eur J Gastroenterol Hepatol (2017) 0.75
Spot stenting of the tear in type B aortic dissection. Ann Vasc Surg (2013) 0.75
[Management of patients with intermittent claudication]. Rev Prat (2005) 0.75
Growth factors improve latissimus dorsi muscle vascularization and trophicity after cardiomyoplasty. Ann Thorac Surg (2003) 0.75
Antegrade, covered, self-expanding stent as an iliac extension in a bifurcated endograft: a feasible technical maneuver for challenging aortoiliac aneurysmal anatomy. Ann Vasc Surg (2011) 0.75